Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus

The spike protein of the SARS-CoV-2 virus is the foremost target for the designing of vaccines and therapeutic antibodies and also acts as a crucial antigen in the assessment of COVID-19 immune responses. The enveloped viruses; such as SARS-CoV-2, Human Immunodeficiency Virus-1 (HIV-1) and influenza...

Descripción completa

Detalles Bibliográficos
Autores principales: Murugavelu, Praveenkumar, Perween, Reshma, Shrivastava, Tripti, Singh, Vanshika, Ahmad Parray, Hilal, Singh, Swarandeep, Chiranjivi, Adarsh Kumar, Thiruvengadam, Ramachandran, Singh, Savita, Yadav, Naveen, Jakhar, Kamini, Sonar, Sudipta, Mani, Shailendra, Bhattacharyya, Sankar, Sharma, Chandresh, Vishwakarma, Preeti, Khatri, Ritika, Kumar Panchal, Anil, Das, Supratik, Ahmed, Shubbir, Samal, Sweety, Kshetrapal, Pallavi, Bhatnagar, Shinjini, Luthra, Kalpana, Kumar, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318684/
https://www.ncbi.nlm.nih.gov/pubmed/34426117
http://dx.doi.org/10.1016/j.intimp.2021.108020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318684/
https://www.ncbi.nlm.nih.gov/pubmed/34426117
http://dx.doi.org/10.1016/j.intimp.2021.108020

Ejemplares similares